Please login to the form below

Insights from patients during the COVID-19 pandemic

We all know how much the COVID-19 pandemic has affected everyone around the world. And within the healthcare industry, priorities have been re-evaluated and processes changed, to ensure that patients keep receiving care.

This has meant changes to the way healthcare professionals and patients communicate and the wider introduction of virtual appointments. At COUCH Health, we’ve conducted research to find out how patients are feeling about these changes, including their feelings towards visiting healthcare centres and the use of telemedicine. We carried out a survey among patients who have any one of these conditions: chronic obstructive pulmonary disorder (COPD), ulcerative colitis (UC), Crohn’s disease (CD) and idiopathic pulmonary fibrosis (IPF). We received over 1000 responses in total – thanks to all the patients who took the time to complete the survey.

Unsurprisingly, our findings reveal that people have concerns and anxiety about visiting healthcare centres, as these pose a risk of exposure to the virus.

“I don’t want to go to the doctor and be around people.”  US patient with IPF

Patients were also worried about wasting doctors time if they booked in appointments.

“The NHS have enough to do, I don’t want to overwhelm them.” UK patient with CD

Based on this and other evidence that shows high numbers of people are avoiding seeking care, considerable efforts will be needed to reassure patients that attending health centres and appointments can be safe. Public health messaging would also be beneficial, to reiterate the importance of seeking medical attention. This will help maintain health (outside of the pandemic) and avoid missed or delayed diagnoses.

Across all disease areas, respondents showed a clear preference for face-to-face appointments vs any other format, even though most people expressed satisfaction with virtual appointments. Some comments suggest that more education is needed about how technology can support virtual appointments and enable simple tests to be carried out.

“It’s not the same. How can a doctor examine me online. Blood pressure, oxygen breathing tests, it wouldn’t work” US patient with IPF

Very few respondents were currently taking part in a clinical trial (for example, only 0.9% of COPD patients and 1.9% of UC patients). On the whole, people reported being happy to carry out clinical tests at home, if given appropriate guidance. Interestingly, patients in all disease areas apart from IPF would prefer to travel to the clinic rather than staying at home after the pandemic. More research into this area would be beneficial to guide how studies introduce remote visits and data collection.

This research gives important insights to how patients feel about their condition, seeking care and telemedicine. The responses highlight that there is no one-size-fits-all approach when it comes to healthcare, and that patient insights are essential to help guide decision-making whether it’s about reassuring patients through public messaging, or introducing more decentralised clinical trials. Further research among patients with other conditions will be important to help guide decision-making during and beyond the pandemic.

Blog was first published here:

9th October 2020



Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Suite 2.10, Jactin House
24 Hood Street
M4 6WX
United Kingdom

Latest content on this profile

COUCH Health publishes report to encourage patient engagement in the MedTech sector
Manchester, UK, 27 February 2023 — COUCH Health today announced the publication of a new report “The Power of Patient Engagement in MedTech”.
COUCH Health
#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need unconscious bias training.”
COUCH Health
How do ethnic minority groups in the U.S. view clinical trials?
This year, we decided to do the same with ethnic minority communities over in the United States (U.S.) too. Ultimately, we wanted to explore attitudes towards clinical trials from these communities, understand the barriers in participation, and determine what factors may influence people’s decisions to take part.
COUCH Health
Three things to consider when using social listening research for patient recruitment
We are looking at how patient research can power your patient recruitment campaign. A look into social listening follows on from this blog perfectly, offering a stronger and more authentic alternative to relying on data trends to guide your activities. So, let’s get started…
COUCH Health
4 ways mobile ethnography studies can elevate your patient insights
How can we achieve more real-life, in-the-moment insights from different groups to understand their thoughts and behaviours? This is where ethnography studies come in.
COUCH Health
#DemandDiversity: We’re calling on the clinical trials industry to include us all
The lack of diversity in clinical trials is something we’ve spoken about time and time again. By now, you might think we sound a bit like a broken record. But, the fact is, many people still aren’t aware of the underrepresentation, especially those who don’t work in the industry. Do you think if the clinical research industry could see the people they were leaving out of clinical trials, and hear how they felt about being underrepresented, it would make a difference?
COUCH Health